Aspira Pathlab & Diagnostics announced a key leadership change: Mr. Pankaj Jashwant Shah has resigned from his positions as Managing Director and Chief Executive Director.

The company cited personal reasons for his departure, effective August 03, 2026. This executive transition impacts the company's top management structure, which is a significant development for its operations and stakeholders.

Investors should be aware of this change in leadership.